Clinical trials
Observational Mouth Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 8 |
| Terminated | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 6 |
| National Cancer Institute (NCI) | 2 |
| University of Colorado, Denver | 2 |
| Viome | 2 |
| AstraZeneca | 1 |
| Case Comprehensive Cancer Center | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Indiana University | 1 |
| Johns Hopkins Bloomberg School of Public Health | 1 |
| Joseph Califano | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mouth Neoplasms | 32 |
| Head and Neck Neoplasms | 13 |
| Oropharyngeal Neoplasms | 10 |
| Laryngeal Neoplasms | 9 |
| Esophageal Neoplasms | 6 |
| Hypopharyngeal Neoplasms | 6 |
| Lung Neoplasms | 6 |
| Nasopharyngeal Neoplasms | 6 |
| Salivary Gland Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.